Topics

It’s Time to Address the Imbalance in Value Assessment

06:30 EST 2 Dec 2019 | MedPageToday

]]>(MedPage Today) -- Ever wonder why most cost-effectiveness studies deal with drug therapies and not other types of treatments? It's really quite puzzling when you think about it. The U.S. spent $481 billion on prescription drugs last year and while...

Original Article: It’s Time to Address the Imbalance in Value Assessment

NEXT ARTICLE

More From BioPortfolio on "It’s Time to Address the Imbalance in Value Assessment"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...